Matthew I. Milowsky, MD, FASCO, presents on "Update in Bladder Cancer"
|
Kevin Chen, PharmD, MS, BCOP, CPP, presents on "Antibody-Drug Conjugates in Oncology: From Bench to Bedside."
|
Michael Galgano, MD, FAANS, will focus on differentiating the various types of spinal tumors, ranging from metastases, to primary vertebral column tumors, and intradural spinal cord tumors. He will discus the contributions of co-morbidities and frailty on the management of patients with spinal tumors. He will also aim to give the audience a brief exposure to the surgical management of spinal oncology, and what is entailed to execute robust local control.
|
Anne W. Beaven, MD, will review recent updates and evolving standard of care for management of Hodgkin and Non-Hodgkin lymphoma.
|
Breast cancer management continues to evolve with tailored therapies allowing for a personalized approach to treatment. This is an update on current surgical considerations for breast cancer management.
|
The management of multiple myeloma is dynamic with a constantly changing landscape. Samuel M. Rubinstein, MD, MSCI, will cover recently published manuscripts and conference presentations that present practice changing data in the management of multiple myeloma.
|
Radiation therapy is an integral part of cancer treatment across many disease sites, but the locoregional control benefits must be weighed against the potential toxicities. During this webinar, Kevin Pearlstein, MD, will review the role of radiation in cancer care including basic radiobiologic principles, logistics, and toxicities. He will discuss several recent studies examining the omission of radiation for different solid malignancies and review strategies to identify patients who will benefit the most from radiation.
|
Dominique Higgins, MD, PhD, provides an overview of diagnostic criteria for primary CNS brain tumors, and the current approved and investigational treatments that are available and on the horizon.
|
Frances Collichio, MD, reviews the common and uncommon side effects of immune check point inhibitors. She also discusses the relatively new concept of delayed immune related events.
|
Joshua Zeidner, MD, presents on "Management of Older Adults with AML: Are We Finally Seeing Light at the End of the Tunnel?"
|